UMEM Educational Pearls

Prophylactic FFP for Procedures?

  • FFP is commonly transfused to correct abnormal coagulation studies prior to performing procedures in nonbleeding critically ill patients.
  • Despite common practice, there is little to no supportive evidence to demonstrate a clinical benefit to transfusing FFP in this patient population.
  • Muller, et al recently evaluated the use of FFP before invasive procedures in critically ill patients.  Brief highlights include:
    • Prospective, randomized, open-label study at 4 sites in the Netherlands
    • 76 adult ICU patients with INRs between 1.5 and 3.0
    • Procedures: central line placement, thoracentesis, percutaneous tracheostomy
    • Result: no difference in major bleeding events between those who received FFP and those randomized to no FFP
  • Take Home Point: In the nonbleeding critically ill patient, routine transfusion of FFP to correct lab abnormalities prior to procedures is not indicated.

References

  1. Hunt B. Bleeding and coagulopathies in critical care. NEJM 2014; 370:847-59.
  2. Muller MC, et al. Transfusion of fresh-frozen plasma in critically ill patients with a coagulopathy before invasive procedures: a randomized clinical trial. Transfusion 2014; epub ahead of print.